XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.93

+2.9%

Nov 18 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (5196)	12/30/1997 10:44:00 AM
From: Edward Paule	Read Replies (2) of 17367

<<<P III also requires patients to be at 8 or higher on the scale for P III also. Must say I do not understand why the need to wait so long>>> George, The answer is simple. Kids must die in the placebo group for rBPI21 to show statistical significance. Unfortunate for them, but that's how the system works. If rBPI21 works at this level, as the open label study seems to show; and level 8 or higher maximizes the probability of death in the placebo group; and this happens often enough so that a trial doesn't last forever; then IMO it's a sound design for a phase III trial. - Ed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next